DMD tRNA therapy (Tevard Biosciences)

N/A

Report date: 2024/04/12 11:21:20

Base Information

Drug NameDMD tRNA therapy (Tevard Biosciences)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > tRNA
Mechanisms of ActionDystrophin expression stimulants
TargetsDystrophin
Therapy Area/IndicationsMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTevard Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesTevard Biosciences IncVertex Pharmaceuticals Incorporated
Inactive CompaniesN/A
Active IndicationsMuscular Dystrophy, Duchenne
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A